Loading...
Central DE Medicamentos Y Artigos M — Pyrazinamide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #9 buyer for Pyrazinamide · $150.0K import value · 3 shipments · MOZAMBIQUE · DGFT Verified
Central DE Medicamentos Y Artigos M is the #9 importer of Pyrazinamide from India with $150.0K in import value and 3 verified shipments. Central DE Medicamentos Y Artigos M holds a 0.0% market share in Pyrazinamide imports based in MOZAMBIQUE. Overall, Central DE Medicamentos Y Artigos M imports 2 pharmaceutical products worth $450.0K across 1 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MACLEODS PHARMACEUTICALS LTD | $18.1M | 361 | 84 |
| LUPIN LIMITED | $16.1M | 321 | 49 |
| MACLEODS PHARMACEUTICALS LIMITED | $7.2M | 143 | 51 |
| MANEESH PHARMACEUTICALS LIMITED | $3.5M | 69 | 24 |
| SVIZERA LABS PRIVATE LIMITED | $1.9M | 39 | 12 |
| MICRO LABS LIMITED | $1.8M | 64 | 23 |
| MANEESH PHARMACEUTICALS LTD | $400.0K | 8 | 5 |
| UNILINK PHARMA PRIVATE LIMITED | $291.1K | 6 | 2 |
| OMNICALS PHARMA PRIVATE LIMITED | $275.2K | 9 | 2 |
| SIMPEX PHARMA PRIVATE LIMITED | $194.8K | 6 | 1 |
India's top Pyrazinamide suppliers include MACLEODS PHARMACEUTICALS LTD, LUPIN LIMITED, MACLEODS PHARMACEUTICALS LIMITED. These companies represent the primary source of Pyrazinamide exports from India, serving buyers like Central DE Medicamentos Y Artigos M in MOZAMBIQUE and other global markets.
India exported $11.3M worth of Pyrazinamide through 1,459 shipments from 90 suppliers to 131 countries, serving 434 buyers globally. Central DE Medicamentos Y Artigos M imports $150.0K of this total, accounting for 0.0% of India's Pyrazinamide exports with 3 shipments from MOZAMBIQUE.
Central DE Medicamentos Y Artigos M's average Pyrazinamide order value is $50.0K per consignment, based on 3 shipments totaling $150.0K. Central DE Medicamentos Y Artigos M is based in MOZAMBIQUE and ranks #9 among all Pyrazinamide importers from India by value.
Top Indian Pyrazinamide suppliers include MACLEODS PHARMACEUTICALS LTD ($18.1M), LUPIN LIMITED ($16.1M), MACLEODS PHARMACEUTICALS LIMITED ($7.2M), MANEESH PHARMACEUTICALS LIMITED ($3.5M), SVIZERA LABS PRIVATE LIMITED ($1.9M). These companies represent the primary source of Pyrazinamide exports from India.
Central DE Medicamentos Y Artigos M ranks #9 among 434 Pyrazinamide importers from India with a 0.0% market share. The top 3 importers are I+SOLUTIONS ($2.6M), NATIONAL TUBERCULOSIS AND LEPROSY ($1.7M), UPD LEA GLEN, PHARMA DYNAMICS C/O ($1.1M). Central DE Medicamentos Y Artigos M processed 3 shipments from MOZAMBIQUE.
Central DE Medicamentos Y Artigos M also imports these tuberculosis medications products. Each links to the detailed product page.
Central DE Medicamentos Y Artigos M imports 2 products worth $450.0K. Beyond Pyrazinamide, top products include Ethambutol. View the complete Central DE Medicamentos Y Artigos M profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Pyrazinamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Central DE Medicamentos Y Artigos M's Pyrazinamide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Central DE Medicamentos Y Artigos M
Full Company Profile →
2 products · $450.0K total trade · 1 categories
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 434+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Central DE Medicamentos Y Artigos M.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pyrazinamide. For current order-level data, contact TransData Nexus.